Researchers Information System

日本語に切り替えるswitch to english

Kishi, Noriko

KYOTO UNIVERSITY HOSPITAL Program-Specific Assistant Professor

Kishi, Noriko
list
    Last Updated :2025/08/06

    Basic Information

    Email Address

    • Email Address

      kishi.noriko.3xkyoto-u.ac.jp

    Academic Degree

    • 24 Nov. 2022
      京都大学博士(医学)

    Academic Resume (Graduate Schools)

    • 京都大学, 大学院医学研究科博士課程医学専攻, 修了
    • 京都大学, 大学院医学研究科博士課程医学専攻, 研究指導認定退学

    Academic Resume (Undergraduate School/Majors)

    • 神戸女学院高等学部, 卒業
    • 京都大学, 医学部医学科, 卒業

    ID,URL

    researchmap URL

    list
      Last Updated :2025/08/06

      Research

      Papers

      • Efficacy of Radiotherapy for Oligometastatic Lung Cancer and Irradiation Methods Based on Metastatic Site
        Katsuyuki Shirai; Masashi Endo; Shuri Aoki; Noriko Kishi; Yukiko Fukuda; Tetsuo Nonaka; Hitoshi Ishikawa
        Cancers, 04 Aug. 2025
      • Do Older Patients With Metastatic Hormone-Sensitive Prostate Cancer Benefit From Triplet or Doublet Therapy? A Network Meta-Analysis
        Susu Zhou; Parissa Alerasool; Noriko Kishi; Che-Kai Tsao
        Clinical Genitourinary Cancer, Aug. 2025
      • Chronic progressive pulmonary aspergillosis within the irradiated field after stereotactic body radiotherapy: two case reports
        Nao Mamuro; Noriko Kishi; Yukinori Matsuo; Masahiro Yoneyama; Hiroyuki Inoo; Minoru Inoue; Takashi Mizowaki
        International Cancer Conference Journal, 21 Jan. 2025
      • Margins to compensate for respiratory-induced mismatches between lung tumor and fiducial marker positions using four-dimensional computed tomography
        Seiya Matsumoto; Nobutaka Mukumoto; Tomohiro Ono; Hiraku Iramina; Hideaki Hirashima; Takanori Adachi; Yuki Miyabe; Noriko Kishi; Takashi Mizowaki; Mitsuhiro Nakamura
        Physics and Imaging in Radiation Oncology, Jan. 2025
      • Optimal duration of consolidation durvalumab following chemoradiotherapy in stage III non-small cell lung cancer: a multi-institutional retrospective study.
        Doi H; Matsuo Y; Kishi N; Ogura M; Mitsuyoshi T; Ueki N; Ueki K; Fujii K; Sakamoto M; Atsuta T; Katagiri T; Sakamoto T; Narabayashi M; Ohtsu S; Fujishiro S; Kishi T; Mizowaki T; Kyoto Radiation; Oncology Study Group; KROSG
        Targeted Oncology, Nov. 2024, Peer-reviewed
      • Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer
        Ueki, Kazuhito; Matsuo, Yukinori; Kishi, Noriko; Yoneyama, Masahiro; Yoshida, Hironori; Sakamori, Yuichi; Ozasa, Hiroaki; Hirai, Toyohiro; Mizowaki, Takashi
        Journal of Radiation Research, Jul. 2022
      • 臨床III期N2非小細胞肺癌の治療戦略 臨床III期N2非小細胞肺癌に対する術前化学放射線療法
        伊達 洋至; 小笹 裕晃; 岸 徳子; 西川 滋人; 毛受 暁史
        肺癌, Oct. 2023
      • Quantitative analysis of interstitial lung abnormalities on computed tomography to predict symptomatic radiation pneumonitis after lung stereotactic body radiotherapy.
        Masahiro Yoneyama; Yukinori Matsuo; Noriko Kishi; Ryo Itotani; Tsuyoshi Oguma; Hiroaki Ozasa; Kiminobu Tanizawa; Tomohiro Handa; Toyohiro Hirai; Takashi Mizowaki
        Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 23 Jun. 2024
      • Validation of the Lung-Mol Graded Prognostic Assessment (GPA) System for the Prognosis of Patients Receiving Radiotherapy for Brain Metastasis From Non-small Cell Lung Cancer.
        Daichi Toriduka; Yukinori Matsuo; Hideki Hanazawa; Noriko Kishi; Megumi Uto; Takashi Mizowaki
        Cureus, Apr. 2024
      • Unifying gamma passing rates in patient-specific QA for VMAT lung cancer treatment based on data assimilation.
        Tomohiro Ono; Takanori Adachi; Hideaki Hirashima; Hiraku Iramina; Noriko Kishi; Yukinori Matsuo; Mitsuhiro Nakamura; Takashi Mizowaki
        Physical and engineering sciences in medicine, 20 Jun. 2024
      • Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials
        Susu Zhou; Parissa Alerasool; Noriko Kishi; Himanshu Joshi; Gagan Sahni; Che-Kai Tsao
        Clinical Genitourinary Cancer, Jun. 2024
      • Protocol of a phase II study to evaluate the efficacy and safety of deep-inspiration breath-hold daily online adaptive radiotherapy for centrally located lung tumours (PUDDING study).
        Noriko Kishi; Masahiro Yoneyama; Hiroyuki Inoo; Minoru Inoue; Hiraku Iramina; Akiyoshi Nakakura; Tomohiro Ono; Hideaki Hirashima; Takanori Adachi; Norimasa Matsushita; Makoto Sasaki; Takahiro Fujimoto; Mitsuhiro Nakamura; Yukinori Matsuo; Takashi Mizowaki
        Radiation oncology (London, England), 08 Mar. 2024

      Misc.

      • EP08.02-32 Optimal Planning Target Volume Margins for Spirometer-Based DIBH Radiotherapy for Lung Cancer
        N. Kishi; Y. Matsuo; T. Ono; N. Matsushita; N. Mukumoto; Y. Tsuruta; M. Sasaki; T. Fujimoto; M. Nakamura; T. Mizowaki
        Journal of Thoracic Oncology, Nov. 2023, Peer-reviewed
      • 当院における非小細胞肺癌脳転移に対する放射線治療成績
        花澤豪樹; 松尾幸憲; 宇藤恵; 竹花恵一; 岸徳子; 溝脇尚志; 金永学; 阪森優一
        肺癌(Web), 2019

      Awards

      • 14 Jun. 2019
        第28回日本定位放射線治療学会 優秀演題賞

      External funds: Kakenhi

      • Establishment of radiotherapy technique to minimise the risk of radiation pneumonitis in locally advanced non-small cell lung cancer.
        Grant-in-Aid for Research Activity Start-up
        0902:General internal medicine and related fields
        Kyoto University
        Noriko Kishi
        From 31 Aug. 2022, To 31 Mar. 2024, Project Closed
        肺癌;放射線治療;放射線性肺臓炎;機械学習
      • Establishment of functional heart and lung-sparing stereotactic body radiotherapy
        Grant-in-Aid for Early-Career Scientists
        Basic Section 52040:Radiological sciences-related
        Kyoto University
        岸 徳子
        From 01 Apr. 2023, To 31 Mar. 2026, Granted
        放射線治療;肺癌;心毒性;体幹部定位放射線治療

      ページ上部へ戻る